Table 2 Incidence of adverse outcomes in ACS patients according to the NLR tertiles
1st tertile ≤ 3.37 (n = 245) | 2nd tertile 3.38–6.93 (n = 245) | 3rd tertile ≥ 6.94 (n = 247) | χ2 | P | |
|---|---|---|---|---|---|
ACM, n (%) | 5 (2.0) | 12 (4.9) | 7 (2.8) | 3.385 | 0.184 |
Non-sudden cardiac death, n (%) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 1.825 | 0.665 |
MACE, n (%) | 21 (8.6) | 24 (9.8) | 20 (8.1) | 0.469 | 0.791 |
CM, n (%) | 4 (1.6) | 12 (4.9) | 7 (2.8) | 4.421 | 0.110 |
Re-myocardial infarction, n (%) | 4 (1.6) | 0 (0.0) | 2 (0.8) | 5.578 | 0.061 |
ST, n (%) | 0 (0.0) | 0 (0.0) | 2 (0.8) | 2.617 | 0.332 |
Revascularization, n (%) | 11 (4.5) | 17 (6.9) | 12 (4.9) | 1.666 | 0.435 |
Stroke, n (%) | 1 (0.4) | 0 (0.0) | 2 (0.8) | 2.764 | 0.251 |
Bleeding events, n (%) | 1 (0.4) | 6 (2.4) | 1 (0.4) | 5.904 | 0.052 |